NCT05960929 - InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

April 1, 2026

Conditions

Respiratory Distress Syndrome (Neonatal)Intubation ComplicationDeath; Neonatal

Interventions

COMBINATION_PRODUCT

Infasurf Aero™

A single dose of Calfactant administered by pacifier interface by inhalation via the Infasurf Aero nebulizer at 6ml/kg.

Trial Locations (10)

RECRUITING

Sisters of Charity Hospital, Buffalo

RECRUITING

University of Florida -Jacksonville, Jacksonville

RECRUITING

Western TN- Jackson-Madison County General Hospital, Jackson

RECRUITING

Unity Point Meriter, Madison

RECRUITING

Utah Valley Hospital, Provo

RECRUITING

St. Josephs Hospital and Medical Center, Phoenix

RECRUITING

Phoenix Children's, Phoenix

RECRUITING

Sharp Mary Birch Hospital for Women & Newborns, San Diego

RECRUITING

Kapi'olani Medical Center for Women & Children, Honolulu

RECRUITING

Jersey Shore University Medical Center, Neptune City